Lipfendra Pill Cuts LDL Cholesterol by 60% in Clinical Studies

3 articles · Updated · 69News WFMZ-TV · Jul 29

Clinical studies found Lipfendra, a once-daily oral pill, lowered LDL cholesterol by about 60% in people with high levels of so-called bad cholesterol.
The drug is aimed at patients whose LDL builds up in arteries and who either cannot take statins or are not getting enough cholesterol reduction from them.
That positions Lipfendra as a pill-based alternative for high-cholesterol treatment, potentially widening options beyond standard statin therapy.

Sources

69News WFMZ-TV7d ago

Lipfendra Pill Clinical Studies Show 60% LDL Cholesterol Reduction

WDBJ7d ago

HOMETOWN HEALTH: FDA approves new once-daily pill to lower LDL cholesterol

Healthline7d ago

FDA Approves New Pill That Lowers Cholesterol Levels By Nearly 60%

4 Sources

If Lipfendra works best alongside statins, which patients should get this new pill before older add-on options like ezetimibe or injectable PCSK9 drugs?

Can Merck’s first oral PCSK9 pill truly change cholesterol care if it cuts LDL by 60% but still hasn’t proven fewer heart attacks or strokes?